BackOrchestra BioMed Holdings Overview

Orchestra BioMed Holdings Long Term Debt

Track Orchestra BioMed Holdings's long-term debt ($21M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$20.96M
↑ 689.23% YoYΔ $18.31M vs prior year quarter

Peer trimmed avg / median

Loading

Orchestra BioMed Holdings Long Term Debt History

Loading

Orchestra BioMed Holdings vs. peers: Long Term Debt Comparison

Loading

Orchestra BioMed Holdings Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Orchestra BioMed Holdings (OBIO) FAQ

Orchestra BioMed Holdings (OBIO) currently reports a long-term debt of $21M as of June 2026. That compares with $2.7M in the prior-year period — up 689.2% year over year. Use the charts on this page to explore Orchestra BioMed Holdings's long-term debt history and peer comparisons.

Orchestra BioMed Holdings's long-term debt increased from $2.7M to $21M — a 689.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orchestra BioMed Holdings reported $21M in long-term debt as of June 2026. That compares with $2.7M in the prior-year period — up 689.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orchestra BioMed Holdings, and consider following OBIO for alerts when major investors trade the stock.